TLPH Talphera Inc.

Price (delayed)

$0.97

Market cap

$16.46M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.29

Enterprise value

$10.74M

acelrx pharmaceuticals inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain. the company’s product candidates, dsuvia™ (known ...

Highlights

Talphera's debt has plunged by 100% YoY

TLPH's revenue has soared by 76% QoQ

TLPH's net income has plunged by 139% YoY but it is up by 14% from the previous quarter

TLPH's EPS has dropped by 123% year-on-year but it is up by 41% since the previous quarter

TLPH's equity is down by 35% YoY and by 23% from the previous quarter

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Website: http://www.acelrx.com

Key stats

What are the main financial stats of TLPH

Market

Shares outstanding

16.97M

Market cap

$16.46M

Enterprise value

$10.74M

Valuations

Price to earnings (P/E)

N/A

Price to book (P/B)

1.17

Price to sales (P/S)

21.25

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

16.5

Earnings

Revenue

$651,000

EBIT

-$18.26M

EBITDA

-$17.95M

Free cash flow

-$17.59M

Per share

EPS

-$1.29

Free cash flow per share

-$1.23

Book value per share

$0.83

Revenue per share

$0.05

TBVPS

$1.43

Balance sheet

Total assets

$20.4M

Total liabilities

$6.29M

Debt

Equity

$14.11M

Working capital

$7.04M

Liquidity

Debt to equity

Current ratio

2.56

Quick ratio

2.08

Net debt/EBITDA

0.32

Margins

EBITDA margin

-2,757.6%

Gross margin

100%

Net margin

-2,826%

Operating margin

-2,594.3%

Efficiency

Return on assets

-83.9%

Return on equity

-128.9%

Return on invested capital

-248.5%

Return on capital employed

-115%

Return on sales

-2,805.4%

Dividend

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

TLPH stock price

How has the Talphera stock price performed over time

Intraday

2.11%

1 week

-3.96%

1 month

-14.91%

1 year

40.27%

YTD

31.97%

QTD

-5.83%

Financial performance

How have Talphera's revenue and profit performed over time

Revenue

$651,000

Gross profit

$651,000

Operating income

-$16.89M

Net income

-$18.4M

Gross margin

100%

Net margin

-2,826%

TLPH's net income has plunged by 139% YoY but it is up by 14% from the previous quarter

TLPH's revenue has soared by 76% QoQ

TLPH's gross profit has soared by 76% QoQ

Talphera's net margin has soared by 51% from the previous quarter

Growth

What is Talphera's growth rate over time

Valuation

What is Talphera stock price valuation

P/E

N/A

P/B

1.17

P/S

21.25

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

16.5

TLPH's EPS has dropped by 123% year-on-year but it is up by 41% since the previous quarter

The P/B is 46% more than the last 4 quarters average of 0.8

TLPH's equity is down by 35% YoY and by 23% from the previous quarter

TLPH's price to sales (P/S) is 98% lower than its 5-year quarterly average of 943.2

TLPH's revenue has soared by 76% QoQ

Efficiency

How efficient is Talphera business performance

The company's return on equity has shrunk by 133% YoY

TLPH's return on sales is up by 50% since the previous quarter

TLPH's ROA is down by 17% since the previous quarter

The company's return on invested capital fell by 15% QoQ

Dividends

What is TLPH's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for TLPH.

Financial health

How did Talphera financials performed over time

TLPH's total liabilities has shrunk by 75% YoY but it is up by 27% QoQ

Talphera's total assets has shrunk by 57% YoY and by 12% QoQ

Talphera's debt is 100% less than its equity

Talphera's debt has plunged by 100% YoY

The debt to equity has plunged by 100% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.